PTC Therapeutics has signed a long-term lease agreement with Bristol-Myers Squibb (BMS) to gain access to approximately 185,000 square feet of space, including an existing state-of-the-art biologics production facility and supporting research and operations buildings on the BMS Hopewell, N.J. campus. PTC plans to further develop the biologics facility to support gene therapy production. In addition, PTC plans to move its research operations to a newly renovated building on the same campus. These...